Oscar Health, Inc. (NYSE:OSCR) CAO Sells $76,025.74 in Stock

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 4,226 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the transaction, the chief accounting officer now directly owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Oscar Health Trading Down 2.4 %

Shares of OSCR opened at $16.99 on Friday. The firm has a market capitalization of $4.03 billion, a price-to-earnings ratio of -42.48, a PEG ratio of 36.25 and a beta of 1.61. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. Oscar Health, Inc. has a 1-year low of $4.72 and a 1-year high of $23.44. The company has a 50-day moving average of $16.98 and a 200 day moving average of $17.23.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. Oscar Health’s quarterly revenue was up 44.6% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.07) earnings per share. On average, research analysts expect that Oscar Health, Inc. will post 0.01 EPS for the current year.

Institutional Investors Weigh In On Oscar Health

Several hedge funds have recently made changes to their positions in OSCR. Vanguard Group Inc. increased its stake in shares of Oscar Health by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after buying an additional 337,850 shares during the period. Formation8 GP LLC bought a new stake in shares of Oscar Health in the 4th quarter valued at about $47,480,000. Price T Rowe Associates Inc. MD lifted its position in shares of Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares during the period. Renaissance Technologies LLC boosted its stake in shares of Oscar Health by 31.7% during the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Oscar Health by 14.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,162,935 shares of the company’s stock valued at $28,942,000 after purchasing an additional 392,837 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on OSCR shares. Robert W. Baird initiated coverage on Oscar Health in a research report on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price on the stock. Baird R W raised shares of Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Wells Fargo & Company increased their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 12th. Piper Sandler boosted their target price on Oscar Health from $25.00 to $28.00 and gave the company an “overweight” rating in a research report on Thursday, August 8th. Finally, Bank of America reiterated a “neutral” rating and issued a $21.00 price target (down from $25.00) on shares of Oscar Health in a report on Thursday, May 30th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $24.17.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.